23andMe's CEO Anne Wojcicki sent an email to customers on Wednesday announcing a $300 million investment from pharma giant GlaxoSmithKline. In the email, Wojcicki says the firms are partnering on
new treatments for Parkinson’s diseases and other illnesses.
Read the whole story at Business Insider »